Wasn't questioning your buy in price, can't prove it, anyone can say whatever they want, so I don't care too much about people's claims. Saying that happen to think you've done ok if that is your buy-in price from a medium-term view. But you've made some remarkable statements. Did you say doji pattern says it will break up, it happens everytime? Did you not wink at someone telling them they'll have to chase the share price from now on? That people had their chance to buy at 44c. Just don't think your charting claims have been very accurate so far. At least you're giving it a go. As for claims this looks a lot like Xero in it's early days, that's just blatant ramping. XERO was a early innovator using the SaaS model, focusing on small business, targetting accountants and the rest is history. PYG has potential but there is immense competition. They need to stop over-paying for acquisitions with money they don't have. Personally I would have preferred they focused on organically building the client base. It may work.out long-term but the weakness has not surprised me at all. Flagged the issues with this acquisition when it was announced and haven't had to look at a chart whatsoever.
I like to keep it real. No need to ramp.
- Forums
- ASX - By Stock
- PYG
- Ann: Record FY21 results deliver positive EBITDA
Ann: Record FY21 results deliver positive EBITDA, page-23
Featured News
Add PYG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online